Neuroimaging Features and Predictors of Outcome in Eclamptic Encephalopathy: A Prospective Observational Study
AJNR 35:1728-1734, Junewar, V.,et al, 2014
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Clnicopathologic Conference Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis
NEJM 379:870-878, CASE 27-2018, 2018
Investigations in GABA? Receptor Antibody-Associated Encephalitis
Neurol 88:1012-1020,1010, Spatola, M.,et al, 2017
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
NEJM 370:Doi:10.1056/NEJMoal1401268, Wilson, M.R.,et al, 2014
Treatment of Severe Neurological Deficits with IgG Depletion through Immunoadsorption in Patients with Escherichia coli O104:H4-Associated Haemolytic Uraemic Syndrome: A Prospective Trial
Lancet 378:1166-1173,1120, Greinacher, A.,et al, 2011
Anti-NMDA Receptor Encephalitis Causing Prolonged Nonconvulsive Status Epilepticus
Neurol 75:1480-1482, Johnson,N.,et al, 2010
Randomized Study of Intravenous Valproate and Phenytoin in Status Epilepticus
Seizure 16:527-532, Agarwal,P.,et al, 2007
Intravenous Sodium Valproate Versus Diazepam Infusion for the Control of Refractory Status Epilepticus in Children: A Randomized Controlled Trial
J Child Neurol 22:1191-1197, Mehta,V.,et al, 2007
Sodium Valproate vs Phenytoin in Status Epilepticus: A Pilot Study
Neurol 67:340-342, Misra,U.K.,et al, 2006
Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurol 64:353-355, Limdi, N.A., et al, 2005
Intravenous Valproic Acid for Myoclonic Status Epilepticus
Neurol 54:1201, Sheth,R.D. & Gidal,B.E., 2000
Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000
Intravenous Valproate is Well Tolerated in Unstable Patients with Status Epilepticus
Neurol 55:722-724, Sinha,S. & Naritoku,D.K., 2000
Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999
Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998
Nonconvulsive Status Epilepticus in Thrombotic Thrombocytopenic Purpura
Neurol 47:1079-1081, Blum,A.S.&Drislane,F.W., 1996
Safety of Intravenous Valproate
Ann Neurol 38:670-674, Devinsky,O.,et al, 1995
Baclofen-induced Generalized Nonconvulsive Status Epilepticus
Ann Neurol 36:113-114, Zak,R.,et al, 1994
New-Onset Seizures in Critically Ill Patients
Neurol 43:1042-1044, Wijdicks,E.F.M.&Sharbrough,F.W., 1993
Clinicopath Conf
Infantile Striatonigral Regeneration, with Cerebellar Degeneration, Familial, Case 30-1992, NEJM 327, 261-1992., 1992
Early Childhood Hepatocerebral Degeneration Misdiagnosed as Valproate Hepatotoxicity
Ann Neurol 32:767-775, Bicknese,A.R.,et al, 1992
Etiology and Mortality of Status Epilepticus in Children, A Recent Update
Arch Neurol 46:74-76, Phillips,S.A.&Shanahan,R.J., 1989
Valproate Prevents the Recurrence of Absence Status
Neurol 39:1294-1297, Berkovic,S.F.,et al, 1989
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Rectal Valproate Syrup & Status Epilepticus
Neurol 30:1113-1114, Thorpy,M.J., 1980
Rectal Administration of Sodium Valproate in Status Epilepticus
Neurol 28:897-899, Vajda,F.J.E.,et al, 1978